FDG pet studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma

Head and Neck

Volumn 24, Issue 2, 2002, Pages 127-135

  Brun, Eva ^a   Kjellén, Elisabeth ^a   Tennvall, Jan ^a   Ohlsson, Tomas ^a   Sandell, Anders ^a   Perfekt, Roland ^a   Wennerberg, Johan ^a   Strand, Sven Erik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; METABOLIC RATE; OUTCOMES RESEARCH; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SURVIVAL RATE; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0036154720     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.10037     Document Type: Article

References (32)

1. Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients
2. Elevated levels of glucose transport and transport messenger RNA are induced by ras or srs oncogenes
3. Glucose catabolism in cancer cells
4. Monitoring response to therapy in cancer using 18F-2-gluoro-2-deoxy-D-glucose and positron emission tomography: An overview of different analytical methods
5. Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy?
6. Evaluation of early response to radiotherapy in head and neck cancer measured with [11-C] methionine-positron emission tomography
7. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: A method for early therapy evaluation?
8. 18F Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer
9. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG-PET
10. Positron emission tomography in non-Hodgkin's lymphoma: Assessment of chemotherapy with fluorodeoxyglucose
11. Early evaluation of tumor metabolic response using 18 F-fluorodeoxyglucose and positron emission tomography: A pilot study after the phase 11 chemotherapy schedule for temozolamide in recurrent high grade gliomas
12. Measurement of clinical and subclinical tumour response using 18 F-fluorodeoxyglucose and positron emission tomography: Review and EORTC 1999 recommendations
13. Early prediction of treatment outcome in head and neck cancer with 2-18 FDG PET
14. A PET-system based on 2-18 FDG production with a low energy electrostatic proton accelerator and dual headed PET scanner
15. Performance study of the PC-384 positron camera system for emission tomography of the brain
16. A new approach to three-dimensional image reconstruction in PET
17. Routine production of 2-deoy-2(18F) fluoro-D-glucose by direct neutrophilic exchange on a quaternary ammonium resin
18. The 14-C deoxyglucose method for the measurement of local cerebral glucose utilization. Theory, procedure and normal values in the conscious and anesthetized albino rat
19. In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas
20. An alternative method to normalize clinical FDG studies
21. The application of PET in clinical oncology
22. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose
23. Pilot studies of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy
24. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography
25. A PET study of 18FDG uptake in soft tissue masses
26. In vitro assessment of 2-fluoro-2-deoxy-D-glucose, 1-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy
27. Radiation induced inhibition of tumor growth as monitored by PET using L-[1-11C] tyrosine and fluorine-18-fluorodeoxyglucose
28. Early changes in fluorine-18-FDG during radiotherapy
29. Reproducibility of metabolic measurements in malignant tumors using FDG-PET
30. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck
31. Effect of nitroimaidazole sensitizers on in vitro glycolytic metabolism of hypoxic squamous cell carcinoma